ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 102627 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 102627; 2) Community: the network communities that were significantly associated with the response to NSC 102627; 3) Molecule: the relationships between components within communities and NSC 102627; 4) MDR: the compounds that were significantly associated with the NSC 102627.

NSC Compound Enrichment Correlation
NSC 634036 4-amino-3-bromo-1-(.beta.-D-ribofuranosyl)pyrrolo[2,3-d] pyridazin-7-one 0.00845932736945076 0.44833798
NSC 639174 Camptothecin Derivative 0.00845932736945076 0.69899099
NSC 670779 Null 0.00845932736945076 0.17962435
NSC 671009 2H-Thieno[3',4':4,5]cyclopent[1,2-d]oxazole- 2,7(7aH)-dione,4,6-dibromo-3,3a-dihydro- 0.00845932736945076 0.16194061
NSC 682840 Butanimidoyl chloride, N-[[[[4-(trifluoromethoxy)phenyl] amino]carbonyl]oxy]- 0.00845932736945076 0.2325862
NSC 684902 Null 0.00845932736945076 0.50460706
NSC 692580 Null 0.00845932736945076 0.33849777
NSC 704637 Null 0.00845932736945076 0.34662384
NSC 706995 Entinostat 0.00845932736945076 0.14586639
NSC 709447 Null 0.00845932736945076 0.24619759
Total:122  Current:32    [First] [Prev] [Next] [Last]